ArticleMedicine2026
Applications and recent advances of 3D printing technology in bone diseases: A bibliometric analysis.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundBone diseases, including osteoporosis, arthritis, and spinal disorders, pose significant global health challenges, especially with an aging population. Traditional treatment methods often fall short in addressing the complexity and variability of these conditions. Three-dimensional (3D) printing technology has emerged as a transformative tool in orthopedics, enabling the creation of patient-specific implants, surgical guides, and anatomical models that enhance precision and personalization in treatment. Despite its potential, challenges such as regulatory barriers, high costs, and limited scalability hinder widespread clinical adoption.
objectiveThis study aims to conduct a bibliometric analysis of the research landscape surrounding the application of 3D printing in bone diseases, identifying emerging trends, influential contributors, and knowledge gaps to inform future research and clinical translation.
methodsThis study analyzed publications on 3D printing in bone diseases from 2005 to 2024 using data from the Web of Science Core Collection. We performed co-occurrence mapping, keyword clustering, and citation analysis using CiteSpace, R Bibliometrix, and GraphPad Prism. We examined trends in research output, collaboration among countries and institutions, and thematic developments.
resultsBetween 2005 and 2024, 544 relevant publications were identified, with a rapid growth phase observed post-2016. China and the USA emerged as leading contributors, collectively accounting for over 50% of global research output. Key application areas included scaffolds for bone regeneration, tissue engineering integrating stem cell technology, and drug delivery systems. Keyword analysis highlighted "scaffolds," "tissue engineering," and "additive manufacturing" as central themes. Despite progress, challenges in standardization, material biocompatibility, and cost-effective manufacturing persist.
conclusion3D printing is reshaping research and clinical applications in bone diseases by offering innovative solutions for bone regeneration, surgical precision, and personalized treatment. Overcoming challenges such as regulatory complexities, scalability, and interdisciplinary collaboration is critical for full clinical integration. Future research should focus on advancing bioprinting techniques, optimizing hybrid manufacturing, and leveraging artificial intelligence -driven design for enhanced patient-specific outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.